Senate Bill sb0178c2

CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2006                     CS for CS for SB 178

    By the Committees on Health and Human Services Appropriations;
    Criminal Justice; and Senator Saunders




    603-2376-06

  1                      A bill to be entitled

  2         An act relating to controlled substances;

  3         creating s. 831.311, F.S.; prohibiting the

  4         sale, manufacture, alteration, delivery,

  5         uttering, or possession of

  6         counterfeit-resistant prescription blanks for

  7         controlled substances; providing penalties;

  8         amending s. 893.04, F.S.; providing additional

  9         requirements for the dispensing of a controlled

10         substance listed in Schedule II, Schedule III,

11         or Schedule IV; providing rulemaking authority

12         to the Board of Pharmacy; creating s. 893.055,

13         F.S.; providing a definition; requiring the

14         Department of Health to establish an electronic

15         system to monitor the prescribing of controlled

16         substances listed in Schedules II, III, and IV;

17         requiring the dispensing of such controlled

18         substances to be reported through the system;

19         providing exceptions; providing reporting

20         requirements; providing penalties; requiring

21         that the department and regulatory boards adopt

22         rules; requiring the department to cover all

23         costs for the system; providing for annual

24         appropriations, subject to availability of

25         funds; prohibiting using funds from the Medical

26         Quality Assurance Trust Fund to administer the

27         program; creating s. 893.065, F.S.; requiring

28         the department to develop and adopt by rule the

29         form and content for a counterfeit-proof

30         prescription blank for voluntary use by

31         physicians to prescribe a controlled substance

                                  1

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         listed in Schedule II, Schedule III, or

 2         Schedule IV; providing an appropriation and

 3         authorizing additional positions; providing for

 4         the contingent applicability of penalties;

 5         providing contingent effective dates.

 6  

 7  Be It Enacted by the Legislature of the State of Florida:

 8  

 9         Section 1.  Section 831.311, Florida Statutes, is

10  created to read:

11         831.311  Unlawful sale, manufacture, alteration,

12  delivery, uttering, or possession of counterfeit-resistant

13  prescription blanks for controlled substances listed in

14  Schedules II, III, and IV.--

15         (1)  It is unlawful for any person having the intent to

16  injure or defraud any person or to facilitate any violation of

17  s. 893.13 to sell, manufacture, alter, deliver, utter, or

18  possess any counterfeit-resistant prescription blanks for

19  controlled substances, the form and content of which are

20  adopted by rule of the Department of Health pursuant to s.

21  893.065.

22         (2)  Any person who violates this section commits a

23  felony of the third degree, punishable as provided in s.

24  775.082, s. 775.083, or s. 775.084.

25         Section 2.  Section 893.04, Florida Statutes, is

26  amended to read:

27         893.04  Pharmacist and practitioner.--

28         (1)  A pharmacist, in good faith and in the course of

29  professional practice only, may dispense controlled substances

30  upon a written or oral prescription of a practitioner, under

31  the following conditions:

                                  2

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         (a)  Oral prescriptions must be promptly reduced to

 2  writing by the pharmacist or recorded electronically if

 3  permitted by federal law.

 4         (b)  The written prescription must be dated and signed

 5  by the prescribing practitioner on the day when issued.

 6         (c)  There shall appear on the face of the prescription

 7  or written record thereof for the controlled substance the

 8  following information:

 9         1.  The full name and address of the person for whom,

10  or the owner of the animal for which, the controlled substance

11  is dispensed.

12         2.  The full name and address of the prescribing

13  practitioner and the practitioner's federal controlled

14  substance registry number shall be printed thereon.

15         3.  If the prescription is for an animal, the species

16  of animal for which the controlled substance is prescribed.

17         4.  The name of the controlled substance prescribed and

18  the strength, quantity, and directions for use thereof.

19         5.  The number of the prescription, as recorded in the

20  prescription files of the pharmacy in which it is filled.

21         6.  The initials of the pharmacist filling the

22  prescription and the date filled.

23         (d)  The prescription shall be retained on file by the

24  proprietor of the pharmacy in which it is filled for a period

25  of 2 years.

26         (e)  Affixed to the original container in which a

27  controlled substance is delivered upon a prescription or

28  authorized refill thereof, as hereinafter provided, there

29  shall be a label bearing the following information:

30         1.  The name and address of the pharmacy from which

31  such controlled substance was dispensed.

                                  3

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         2.  The date on which the prescription for such

 2  controlled substance was filled.

 3         3.  The number of such prescription, as recorded in the

 4  prescription files of the pharmacy in which it is filled.

 5         4.  The name of the prescribing practitioner.

 6         5.  The name of the patient for whom, or of the owner

 7  and species of the animal for which, the controlled substance

 8  is prescribed.

 9         6.  The directions for the use of the controlled

10  substance prescribed in the prescription.

11         7.  A clear, concise warning that it is a crime to

12  transfer the controlled substance to any person other than the

13  patient for whom prescribed.

14         (f)  A prescription for a controlled substance listed

15  in Schedule II may be dispensed only upon a written

16  prescription of a practitioner, except that in an emergency

17  situation, as defined by regulation of the Department of

18  Health, such controlled substance may be dispensed upon oral

19  prescription but is limited to a 72-hour supply. A No

20  prescription for a controlled substance listed in Schedule II

21  may not be refilled.

22         (g)  A No prescription for a controlled substance

23  listed in Schedule Schedules III, Schedule IV, or Schedule V

24  may not be filled or refilled more than five times within a

25  period of 6 months after the date on which the prescription

26  was written unless the prescription is renewed by a

27  practitioner.

28         (2)(a)  A pharmacist may not dispense a controlled

29  substance listed in Schedule II, Schedule III, or Schedule IV

30  to any patient or patient's agent without first determining,

31  in the exercise of her or his professional judgment, that the

                                  4

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1  order is valid. The pharmacist or pharmacist's agent shall

 2  obtain a government-issued or other form of documentary

 3  identification substantiating the identity of a patient or

 4  patient's agent prior to dispensing any Schedule II, Schedule

 5  III, or Schedule IV controlled substance to such patient or

 6  patient's agent. The pharmacist or pharmacist's agent shall

 7  make a record of the type of documentary identification

 8  provided by the patient or patient's agent. If the patient or

 9  patient's agent does not have appropriate identification, the

10  pharmacist may dispense the controlled substance only when the

11  pharmacist determines, in the exercise of her or his

12  professional judgment, that the order is valid and includes

13  such information in the patient's record. The Board of

14  Pharmacy may adopt, by rule, required patient-identification

15  information for controlled substances and procedures for a

16  pharmacist to verify the validity of a prescription for

17  controlled substances for circumstances in which the

18  pharmacist was not provided required identification

19  information.

20         (b)  Any pharmacist who dispenses by mail a controlled

21  substance listed in Schedule II, Schedule III, or Schedule IV

22  is exempt from the requirement to obtain suitable

23  identification for the prescription dispensed by mail if the

24  pharmacist has obtained the patient's identification through

25  the patient's prescription benefit plan.

26         (c)  Any controlled substance listed in Schedule III or

27  Schedule IV may be dispensed by a pharmacist upon an oral

28  prescription if, before filling the prescription, the

29  pharmacist reduces it to writing or records the prescription

30  electronically if permitted by federal law. Such prescriptions

31  must contain the date of the oral authorization.

                                  5

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         (d)  Each written prescription prescribed by a

 2  practitioner in this state for a controlled substance listed

 3  in Schedule II, Schedule III, or Schedule IV must include both

 4  a written and a numerical notation of the quantity on the face

 5  of the prescription and a notation of the date, with the

 6  abbreviated month written out on the face of the prescription.

 7  A pharmacist may, upon verification by the prescriber,

 8  document any information required by this paragraph.

 9         (e)  A pharmacist may not dispense more than a 30-day

10  supply of a controlled substance listed in Schedule III upon

11  an oral prescription issued in this state.

12         (f)  A pharmacist may not knowingly fill a prescription

13  that has been forged for a controlled substance listed in

14  Schedule II, Schedule III, or Schedule IV.

15         (3)(2)  Notwithstanding the provisions of subsection

16  (1), a pharmacist may dispense a one-time emergency refill of

17  up to a 72-hour supply of the prescribed medication for any

18  medicinal drug other than a medicinal drug listed in Schedule

19  II, in compliance with the provisions of s. 465.0275.

20         (4)(3)  The legal owner of any stock of controlled

21  substances in a pharmacy, upon discontinuance of dealing in

22  controlled substances, may sell said stock to a manufacturer,

23  wholesaler, or pharmacy.  Such controlled substances may be

24  sold only upon an order form, when such an order form is

25  required for sale by the drug abuse laws of the United States

26  or this state, or regulations pursuant thereto.

27         Section 3.  Section 893.055, Florida Statutes, is

28  created to read:

29         893.055  Electronic-monitoring system for prescription

30  of controlled substances listed in Schedules II, III, and

31  IV.--

                                  6

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         (1)  As used in this section, the term "pharmacy" means

 2  any pharmacy subject to licensure or regulation by the

 3  Department of Health pursuant to chapter 465 which dispenses

 4  or delivers a controlled substance included on Schedule II,

 5  Schedule III, or Schedule IV to a patient in this state.

 6         (2)  By June 30, 2007, the Department of Health shall

 7  design and establish an electronic system consistent with

 8  standards of the American Society for Automation in Pharmacy

 9  to monitor the prescribing and dispensing of controlled

10  substances listed in Schedules II, III, and IV by health care

11  practitioners within the state and the dispensing of such

12  controlled substances to an individual at a specific address

13  within the state by a pharmacy permitted or registered by the

14  Board of Pharmacy.

15         (3)  Any controlled substance listed in Schedule II,

16  Schedule III, or Schedule IV which is dispensed to an

17  individual in this state must be reported to the Department of

18  Health through the system as soon thereafter as possible, but

19  not more than 35 days after the date the controlled substance

20  is dispensed, each time the controlled substance is dispensed.

21  A pharmacy or dispensing practitioner may meet the reporting

22  requirements of this section by providing to the Department of

23  Health in written or any electronic or magnetic format,

24  including, but not limited to, electronic submission via the

25  Internet or magnetic disc or tape, each controlled substance

26  listed in Schedule II, Schedule III, or Schedule IV which it

27  dispenses.

28         (4)  This section does not apply to controlled

29  substances:

30         (a)  Administered by a health care practitioner

31  directly to a patient.

                                  7

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1         (b)  Dispensed by a health care practitioner authorized

 2  to prescribe controlled substances directly to a patient and

 3  limited to an amount adequate to treat the patient for a

 4  period of no more than 72 hours.

 5         (c)  Dispensed by a health care practitioner or a

 6  pharmacist to an inpatient of a facility that holds an

 7  institutional pharmacy permit.

 8         (d)  Ordered from an institutional pharmacy permitted

 9  under s. 465.019 in accordance with the institutional policy

10  for such controlled substances or drugs.

11         (e)  Dispensed by a pharmacist or administered by a

12  health care practitioner to a patient or resident receiving

13  care from a hospital, nursing home, assisted living facility,

14  home health agency, hospice, or intermediate care facility for

15  the developmentally disabled which is licensed in this state.

16         (f)  Prescribed by a health care practitioner for a

17  patient younger than 16 years of age.

18         (5)  The data required to be reported under this

19  section shall be determined by the Department of Health by

20  rule but may include any data required under s. 893.04.

21         (6)  A practitioner or pharmacist who dispenses a

22  controlled substance under this section must submit the

23  information required by this section in an electronic or other

24  format approved by rule of the Department of Health. The cost

25  to the dispenser in submitting the information required by

26  this section may not be material or extraordinary. Costs not

27  considered to be material or extraordinary include, but are

28  not limited to, regular postage, compact discs, zip-drive

29  storage, regular electronic mail, magnetic tapes, diskettes,

30  and facsimile charges. The information submitted to the

31  Department of Health under this section may be transmitted to

                                  8

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1  any person or agency authorized to receive it pursuant to

 2  section 1 of Senate Bill 176, or similar legislation, and that

 3  person or agency may maintain the information received for up

 4  to 24 months before purging the information from its records.

 5  All transmissions required by this subsection must comply with

 6  relevant federal and state privacy and security laws. However,

 7  any authorized agency receiving such information may maintain

 8  it for longer than 24 months if the information is pertinent

 9  to an ongoing investigation or prosecution.

10         (7)  Any person who knowingly fails to report the

11  dispensing of a controlled substance listed in Schedule II,

12  Schedule III, or Schedule IV as required by this section

13  commits a misdemeanor of the first degree, punishable as

14  provided in s. 775.082 or s. 775.083.

15         (8)  The Department of Health and the regulatory boards

16  for the health care practitioners subject to this section

17  shall adopt rules pursuant to ss. 120.536(1) and 120.54 to

18  administer this section.

19         (9)  All costs incurred by the Department of Health in

20  administering the prescription-monitoring system shall be

21  borne by the department, and an amount necessary to cover such

22  costs shall be appropriated annually, subject to the

23  availability of funds, from the Grants and Donations Trust

24  Fund. The Medical Quality Assurance Trust Fund may not be used

25  to administer or otherwise fund this program.

26         Section 4.  Section 893.065, Florida Statutes, is

27  created to read:

28         893.065  Counterfeit-resistant prescription blanks for

29  controlled substances listed in Schedules II, III, and

30  IV.--The Department of Health shall develop and adopt by rule

31  the form and content for a counterfeit-resistant prescription

                                  9

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1  blank which may be used by practitioners to prescribe a

 2  controlled substance listed in Schedule II, Schedule III, or

 3  Schedule IV. The Department of Health may require the

 4  prescription blanks to be printed on distinctive, watermarked

 5  paper and to bear the preprinted name, address, and category

 6  of professional licensure of the practitioner and that

 7  practitioner's federal registry number for controlled

 8  substances. The prescription blanks may not be transferred.

 9         Section 5.  The sum of $2,564,670 in recurring general

10  revenue funds and $1,837,677 in nonrecurring general revenue

11  funds are appropriated to the Department of Health to

12  implement the provisions of this bill.  Three additional

13  full-time equivalent positions are authorized for the

14  2006-2007 fiscal year to implement the provisions of ss.

15  893.055 and 893.065, Florida Statutes, as created by this act.

16         Section 6.  The penalties created in ss. 831.311(2) and

17  893.055(7), Florida Statutes, by this act shall take effect

18  only upon the adoption by the Department of Health and each

19  applicable professional regulatory board of the rules required

20  pursuant to ss. 893.055(8) and 893.065, Florida Statutes, as

21  created by this act.

22         Section 7.  Except as otherwise expressly provided in

23  this act, this act shall take effect July 1, 2006, if Senate

24  Bill 176, or similar legislation, is adopted in the same

25  legislative session or an extension thereof and becomes law.

26  

27  

28  

29  

30  

31  

                                  10

CODING: Words stricken are deletions; words underlined are additions.






    Florida Senate - 2006                     CS for CS for SB 178
    603-2376-06




 1          STATEMENT OF SUBSTANTIAL CHANGES CONTAINED IN
                       COMMITTEE SUBSTITUTE FOR
 2                          CS for SB 178

 3                                 

 4  Provides that any pharmacist who dispenses by mail a
    controlled substance listed in Schedule II, Schedule III, or
 5  Schedule IV is exempt from the requirement to obtain suitable
    identification for the prescription dispensed by mail provided
 6  the pharmacist has patient identification through a
    prescription benefit plan.
 7  
    Changes the amount of the appropriation and the source of
 8  funds from the Grants and Donations Trust Fund to the General
    Revenue Fund.
 9  

10  

11  

12  

13  

14  

15  

16  

17  

18  

19  

20  

21  

22  

23  

24  

25  

26  

27  

28  

29  

30  

31  

                                  11

CODING: Words stricken are deletions; words underlined are additions.